Nu Skin Enterprises, Inc.
NUS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $342 | $965 | $2,108 | $2,547 |
| - Cash | $187 | $256 | $265 | $340 |
| + Debt | $478 | $607 | $521 | $504 |
| Enterprise Value | $634 | $1,317 | $2,364 | $2,711 |
| Revenue | $1,732 | $1,969 | $2,226 | $2,696 |
| % Growth | -12% | -11.5% | -17.4% | – |
| Gross Profit | $1,182 | $1,357 | $1,595 | $2,020 |
| % Margin | 68.2% | 68.9% | 71.7% | 75% |
| EBITDA | -$79 | $203 | $175 | $368 |
| % Margin | -4.6% | 10.3% | 7.9% | 13.7% |
| Net Income | -$147 | $9 | $105 | $147 |
| % Margin | -8.5% | 0.4% | 4.7% | 5.5% |
| EPS Diluted | -2.95 | 0.17 | 2.07 | 2.86 |
| % Growth | -1,835.3% | -91.8% | -27.6% | – |
| Operating Cash Flow | $112 | $119 | $108 | $142 |
| Capital Expenditures | -$42 | -$58 | -$59 | -$69 |
| Free Cash Flow | $70 | $60 | $49 | $73 |